Injectable Suspensions Having Improved Injectability Properties

Patent No. EP2269577 (titled "Injectable Suspensions Having Improved Injectability Properties") was filed by Alkermes Controlled Therapeutics on Apr 19, 2001. The application was issued on Mar 16, 2016.

Patent Summary

Patent Family

Patent family tree
Statuses, jurisdictions and citation links are shared on request.

Patent Oppositions (4)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
NANJING LUYE PHARMACEUTICALDec 16, 2016ROSSLER
DEHNSDec 15, 2016DEHNS
TEVA PHARMACEUTICAL INDUSTRIES LTDDec 15, 2016D YOUNG
PHARMATHENDec 14, 2016APPLEYARD LEES

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

EP2269577

ALKERMES CONTROLLED THERAPEUTICS
Application Number
EP10174743A
Filing Date
Apr 19, 2001
Status
Revoked
Feb 18, 2022
Publication Date
Mar 16, 2016